In vivo gene delivery mediated by non-viral vectors for cancer therapy

R Mohammadinejad, A Dehshahri… - Journal of Controlled …, 2020 - Elsevier
Gene therapy by expression constructs or down-regulation of certain genes has shown great
potential for the treatment of various diseases. The wide clinical application of nucleic acid …

Poly (amidoamine)(PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

J Li, H Liang, J Liu, Z Wang - International journal of pharmaceutics, 2018 - Elsevier
Abstract Poly (amidoamine)(PAMAM) dendrimers are well-defined, highly branched
macromolecules with numerous active amine groups on the surface. Because of their …

Emerging therapies for hepatocellular carcinoma (HCC)

E Chakraborty, D Sarkar - Cancers, 2022 - mdpi.com
Simple Summary Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is
considered to be a major global health challenge. Due to delays in diagnosis at early …

Chitosan for gene delivery: Methods for improvement and applications

D Chuan, T Jin, R Fan, L Zhou, G Guo - Advances in colloid and interface …, 2019 - Elsevier
Gene therapy is a promising strategy for treating challenging diseases. The successful
delivery of genes is a critical step for gene therapy. However, concerns about …

Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics

M Ashrafizadeh, Z Ahmadi, N Mohamadi… - International journal of …, 2020 - Elsevier
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …

Galactose engineered nanocarriers: Hopes and hypes in cancer therapy

M Fatima, R Karwasra, WH Almalki, A Sahebkar… - European Polymer …, 2023 - Elsevier
For specific targeting of cancer tissues, adequate information about the cancer tissue
environment, cancer cell pathology, and available methods and limits of such methods is …

[HTML][HTML] Current status of nanomaterial-based treatment for hepatocellular carcinoma

B Baig, SA Halim, A Farrukh, Y Greish… - Biomedicine & …, 2019 - Elsevier
Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

M Li, W Zhang, B Wang, Y Gao, Z Song… - International Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …

Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma

B Roy, S Ghose, S Biswas - Seminars in Cell & Developmental Biology, 2022 - Elsevier
Malignancies of hepatocellular carcinoma (HCC) are rapidly spreading and commonly fatal.
Like most cancers, the gene expression patterns in HCC vary significantly from patient to …

Polysaccharide-based nanoparticles for gene delivery

MS Huh, EJ Lee, H Koo, JY Yhee, KS Oh, S Son… - Polymeric gene delivery …, 2018 - Springer
Nanoparticles based on nanotechnology and biotechnology have emerged as efficient
carriers for various biopharmaceutical agents including proteins and genes. In particular …